Ixabepilone to Treat Cervical Cancer

NCT00924066 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

41

Enrollment

NIH

Sponsor class

Stopped Premature closure due to slow/insufficient accrual.

Conditions

Cervical Carcinoma
Cervical Adenocarcinoma
Cervical Adenosquamous Carcinoma
Cervical Carcinoma, Non-SquamousType

Interventions

DRUG: Ixempra (Ixabepilone (BMS-247550) )

Sponsor

National Cancer Institute (NCI)